HAYDEN MICHAEL R purchased 500.0% of their position (20K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $1.06M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/31/2026ACC: 0000874015-26-000254
+20K
Net shares
Net buyer
$1.06M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
20K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+15K
Price / share
$53.38
Trade value
$800.70K
% of position
375.0%
7/30/2026
4K→19K
Common Stock
Indirect
Shares
+5K
Price / share
$51.60
Trade value
$258K
% of position
26.3%
7/31/2026
19K→24K
Total
Net shares
+20K
Net value
$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/30/2026 | P · Purchase | +15K | $53.38 | $800.70K | 375.0% | 4K | 19K |
| Common Stock Indirect | 7/31/2026 | P · Purchase | +5K | $51.60 | $258K | 26.3% | 19K | 24K |
| Total | +20K | $1.06M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned54.30K
Total
54.30K direct54.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 54.30K | Direct |
| Total | 54.30K | 54.30K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported